EssilorLuxottica: Q2/H1 2026 Results - Solid revenue trajectory at +9.7% in H1, with Q2 at +8.7%. Increasing profitability, with Adj. Operating Profit +15%.
EssilorLuxottica (ESLOY) reported H1 2026 revenue growth of 9.7% at constant exchange rates, with Q2 up 8.7%.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
EssilorLuxottica (ESLOY) reported H1 2026 revenue growth of 9.7% at constant exchange rates, with Q2 up 8.7%. Adjusted operating profit rose 15%, with adjusted operating margin reaching 18.6%, or 18.9% at constant exchange rates, expanding by 80 bps.
Q2 retail comparable-store sales grew 8.0%; North America, EMEA and Latin America increased high single digit, Asia-Pacific double digit. The myopia portfolio grew 24% in Q2 revenue, AI glasses nearly doubled, and H1 free cash flow reached €1.07 billion, over €100 million above 2025. The company also started a strategic partnership with Applied Materials on intelligent optical systems.
Positive
- H1 2026 revenue +9.7% at constant exchange rates; Q2 +8.7%
- Adjusted operating profit +15% at constant exchange rates in H1 2026
- Adjusted operating margin 18.6% reported, 18.9% at constant FX, +80 bps
- Free cash flow €1.07 billion in H1, >€100 million above 2025
- Retail comparable-store sales +8.0% in Q2 2026
- Myopia portfolio revenue +24% in Q2 2026
- AI glasses revenue almost doubled in Q2 2026
Negative
- None.
Details
News Market Reaction – ESLOY
On Jul 28, the day this news came out, ESLOY closed 2.72% above the previous close. That session’s volume was 1.9x the stock’s average daily volume.
Data tracked by StockTitan Argus for the Jul 28 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Solid revenue1 trajectory at +
Increasing profitability, with Adj. Operating Profit1,2 +
- Group’s revenue grew
9.7% in H1 at constant exchange rates1, with Q2 at +8.7% - Retail comparable-store sales3 +
8.0% in Q2, with optical and sun banners equally contributing - North America, EMEA and Latin America up high-single digit in Q2, Asia-Pacific up double digits
- Core eyecare/eyewear business steadily growing mid-single digit in Q2 and H1
- Myopia portfolio confirmed as a growth engine, growing
24% in revenue in Q2 - AI glasses almost doubling in revenue in Q2
- Adjusted2 operating margin expanding up to
18.6% , gaining 80bps to18.9% at constant exchange rates1 - Free cash flow4 at
Euro 1.07 billion in H1, more thanEuro 100 million above 2025 - Started strategic partnership with Applied Materials, focusing on new generations of intelligent optical systems
Paris, France (July 28, 2026 - 6:00 pm) – The Board of Directors of EssilorLuxottica met on July 28, 2026 to approve the condensed consolidated interim financial statements for the six months ended June 30, 2026. The Statutory Auditors have performed a limited review of these financial statements.
Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO at EssilorLuxottica commented: “We’re proud to report a successful first half, delivering nearly double-digit revenue growth while increasing adjusted operating profit by
Attachment
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.